
Is Surgery for Ulcerative Colitis (UC) Right for you?
Surgery for ulcerative colitis (UC) is considered when medication and diet changes are ineffective, with about 9.2% of patients eventually undergoing colectomy. Common surgeries include proctocolectomy, ileostomy, and ileal pouch-anal anastomosis (IPAA).
After surgery, you may need an ileostomy or an ileoanal pouch to manage waste. Recovery and adaptation to life post-surgery require medical support and patient education.
Surgery can significantly improve quality of life and eliminate symptoms for many patients. Long-term follow-up is essential to monitor for potential complications. It's important to discuss all the options fully with your doctor to decide if this option is right for you.
Surgery is one of the many treatment options available for people with ulcerative colitis (UC). However, not everyone with this condition will need surgery.
You may be able to manage UC through medication and changes to your diet. Over time, the initial treatments your doctor prescribed may no longer work, or they may become less effective.
How many people have surgery?
In a 2018 study of Swiss people with UC, researchers found that 9.2% of the study participants eventually underwent colectomy (colon removal). They also found that:
5 years after diagnosis, 4.1 percent of people had received a colectomy
10 years after diagnosis, 6.4 percent of people had received a colectomy
15 years after diagnosis, 10.4 percent of people had received a colectomy
20 years after diagnosis, 14.4 percent of people had received a colectomy
Most people had their colectomies performed within 10 years of being diagnosed. Surgery rates for people who'd lived with UC for at least 15 years were significantly lower than rates for people who'd been diagnosed more recently.
Ileostomy
After having UC surgery, your doctor will need to create a way for your body to eliminate waste.
A procedure known as an ileostomy can help. In an ileostomy, your ileum (the final section of the small intestine) is connected to your abdominal wall.
You'll need a stoma as part of the procedure. A stoma is a surgically created opening that allows waste from your intestines to exit your body. A stoma is typically made in the lower abdomen, just below the waist.
Proctocolectomy
Proctocolectomy is the most common type of UC surgery.
A proctocolectomy is performed in the hospital as an inpatient operation. This means you'll stay in the hospital during the procedure and for part of your recovery. You'll need to receive general anesthesia.
After you have a proctocolectomy, you'll also need an ileostomy or an ileal pouch-anal anastomosis (IPAA) to help you eliminate waste.
In most cases, your doctor will conduct both procedures on the same day so you don't have to have general anesthesia again.
In a total proctocolectomy, the anus is also removed.
Ileal pouch-anal anastomosis (IPAA)
Ileal pouch-anal anastomosis (IPAA) is sometimes called a J-pouch surgery. In this procedure, the ileum is converted into a pouch shaped like the letter 'J.' The pouch is then connected to your anal canal.
IPAA is usually effective, but it hasn't been around as long as ileostomy has. This means it may be more difficult to find a surgeon who can perform the procedure.
This procedure is typically performed in two or three stages over the course of 2 or 3 months. You may receive a temporary ileostomy while your pouch heals.
What to expect
As with the ileostomy, you'll need a proctocolectomy before an IPAA. An IPAA is performed in a hospital, and you'll receive general anesthesia.
The IPAA won't function like a normal bowel and rectum at first. You may have bowel leakage for several weeks while you learn to control the internal pouch. Medications may help control the function of the pouch.
If you're planning to give birth to children in the future, talk with your doctor about this before the procedure. This procedure may lead to infertility in some people.
Continent ileostomy
Another type of ileostomy is continent ileostomy or K-pouch surgery. The K-pouch is also known as a Kock pouch, hence its name.
During this procedure, the end of your ileum is secured against the inside of your abdomen.
Unlike a traditional ileostomy, you don't need to wear an ostomy bag. A K-pouch is also different from a J-pouch in that the ileum isn't connected with the anus. Instead, a continent ileostomy relies on an internal human-made valve that collects waste and prevents the waste from draining out.
When the K-pouch gets full, waste is removed via a catheter. You'll need to use a stoma cover and drain the pouch often, at least a few times per day.
After your UC surgery, you'll stay in the hospital for 3 to 7 days. This window of time allows your surgeon to monitor you for signs of complications.
Both ileostomies and pouch surgeries will require a 4- to 6-week recovery period.
During this time, you'll meet regularly with your surgeon, doctor, and possibly an enterostomal therapist.
An enterostomal therapist is a specialized therapist who works directly with people who've had their colon removed.
Your care team will likely cover the following points with you to help improve your recovery:
Eat well: Good nutrition can help your body heal and help you avoid post-operation health issues. Nutrition absorption can be an issue after these surgeries, so eating well will help you maintain healthy levels of nutrients.
Hydrate: Hydration is important for your overall health but especially for your digestive health. Drink six to eight glasses per day at a minimum.
Stay active: Work with a rehab therapist or a physical therapist to slowly recover your physical capabilities, and exercise when you can. Staying active is a great way to care for your overall health as you recover, but too much activity too soon could complicate your recovery.
Manage stress: Anxiety or emotional stress can cause stomach issues, which can increase your risk of an accident.
Surgery risks
Surgery is usually a last-resort option for UC, partly due to the fact that any surgery can pose risks and complications. Some of the risks of UC surgery include:
bleeding
infection
scarring
itching or irritation of the stoma
organ damage
blocked intestines from scar tissue buildup
diarrhea
excessive gas
rectal discharge
nutritional deficiencies, especially vitamin B12
electrolyte imbalances
Bowel surgery may also increase your risk of developing phantom rectum. A phantom rectum refers to the feeling of having to pass a bowel movement even though you no longer have a rectum. This can occur for several years postsurgery.
Meditation, antidepressants, and over-the-counter (OTC) pain relievers may help with phantom rectum.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Pharmacy warning of unsustainable demand for weight loss medication
The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be unsustainable, citing a significant mismatch between public interest and clinical suitability for the treatments. The NPA, which represents over 6,000 independent community pharmacies, highlighted this concern. A poll commissioned by the association revealed that 21 per cent of respondents had attempted to access weight loss treatments in the past year, either online or directly from a pharmacy. This figure surged to 35 per cent among 16 to 34-year-olds, contrasting sharply with just seven per cent of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
Yahoo
2 hours ago
- Yahoo
Brains Aged Faster In 2021–2022: What Did The Pandemic Do To Us?
A new study suggests that the pandemic may have had a significant impact on our brains, whether or not we contracted COVID-19. Leveraging an extensive database of brain scans, British researchers say that people's brains showed accelerated aging during 2021 and 2022, including signs of shrinkage. While people who were infected with COVID also showed cognitive decline, like slower processing speed, the study was notable because it said even the non-infected were likely to experience harm to their brain. While the study did not delve into the exact causes of the accelerated aging, the study's first author, Ali-Reza Mohammadi-Nejad, a neuroimaging researcher at the University of Nottingham, theorizes that it may have been the result of stress and other factors. 'But it is likely that the cumulative experience of the pandemic—including psychological stress, social isolation, disruptions in daily life, reduced activity and wellness—contributed to the observed changes… In this sense, the pandemic period itself appears to have left a mark on our brains, even in the absence of infection,' said Mohammadi-Nejad, per NBC. The researchers found that males and 'those from more socioeconomically deprived backgrounds' experienced the most significant brain aging. Overall, the pandemic was thought to be linked to a 5.5-month acceleration in the aging process. This is not the first time researchers have reached similar conclusions. Last year, a previous study found that teenagers experienced dramatic brain aging during the pandemic. Notably, the study suggested that girls' brains aged 4.2 years faster and boys' brains aged 1.3 years faster, on average. The latest study does not indicate whether the structural changes identified in individuals who have never contracted COVID will result in any noticeable changes in brain function. Nor does the study confirm whether the physical changes will persist over the long term, says Adam Brickman, a professor of neuropsychology at Columbia University Vagelos College of Physicians and Surgeons, who was not involved in the study.


Bloomberg
3 hours ago
- Bloomberg
Roche to Test Whether New Drug Can Prevent Alzheimer's Disease
Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, its latest investment in one of the most failure-prone areas of drugmaking. The new late-stage study will focus on people who are at risk of cognitive decline, Roche said in a statement late Sunday. The goal would be to slow down the emergence of symptoms, or prevent them entirely.